mithracin Sentence Examples
- Mithracin, an antibiotic derived from Streptomyces argillaceus, exhibits potent antitumor activity against various types of cancer.
- The biosynthesis pathway for mithracin involves several unique enzymatic reactions, including the formation of a highly reactive epoxyether.
- Mithracin targets DNA topoisomerase I, a key enzyme involved in DNA replication, leading to DNA damage and cell death.
- Due to its potent antitumor activity, mithracin has been studied as a potential therapeutic agent in clinical trials.
- Mithracin derivatives have been developed to improve its stability and reduce its toxicity, enhancing its potential for clinical applications.
- Researchers investigate the mechanism of action of mithracin to identify key molecular targets for cancer therapy.
- Mithracin has a high affinity for AT-rich DNA sequences, influencing its binding and activity within tumor cells.
- Mithracin's interaction with topoisomerase I induces DNA strand breaks, initiating cellular apoptosis and suppressing tumor growth.
- The development of mithracin-based therapies faces challenges related to drug resistance and off-target effects, requiring further research.
- Mithracin's unique chemical structure and potent antitumor properties continue to inspire the design of novel cancer therapies.
mithracin Meaning
Wordnet
mithracin (n)
an antineoplastic drug (trade name Mithracin) used to treat cancer of the testes
Synonyms & Antonyms of mithracin
No Synonyms and anytonyms found
FAQs About the word mithracin
an antineoplastic drug (trade name Mithracin) used to treat cancer of the testes
No synonyms found.
No antonyms found.
Mithracin, an antibiotic derived from Streptomyces argillaceus, exhibits potent antitumor activity against various types of cancer.
The biosynthesis pathway for mithracin involves several unique enzymatic reactions, including the formation of a highly reactive epoxyether.
Mithracin targets DNA topoisomerase I, a key enzyme involved in DNA replication, leading to DNA damage and cell death.
Due to its potent antitumor activity, mithracin has been studied as a potential therapeutic agent in clinical trials.
